BR0109996A - Uso de agentes bradicardìacos no tratamento de doenças miocárdicas acompanhadas de hipertrofia, e novas combinações de drogas - Google Patents

Uso de agentes bradicardìacos no tratamento de doenças miocárdicas acompanhadas de hipertrofia, e novas combinações de drogas

Info

Publication number
BR0109996A
BR0109996A BR0109996-5A BR0109996A BR0109996A BR 0109996 A BR0109996 A BR 0109996A BR 0109996 A BR0109996 A BR 0109996A BR 0109996 A BR0109996 A BR 0109996A
Authority
BR
Brazil
Prior art keywords
hypertrophy
treatment
diseases accompanied
new drug
drug combinations
Prior art date
Application number
BR0109996-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Juergen Daemmgen
Brian Guth
Randolph Seidler
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of BR0109996A publication Critical patent/BR0109996A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR0109996-5A 2000-04-13 2001-04-07 Uso de agentes bradicardìacos no tratamento de doenças miocárdicas acompanhadas de hipertrofia, e novas combinações de drogas BR0109996A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10018401A DE10018401A1 (de) 2000-04-13 2000-04-13 Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
PCT/EP2001/004034 WO2001078699A2 (de) 2000-04-13 2001-04-07 Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen

Publications (1)

Publication Number Publication Date
BR0109996A true BR0109996A (pt) 2003-05-27

Family

ID=7638652

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109996-5A BR0109996A (pt) 2000-04-13 2001-04-07 Uso de agentes bradicardìacos no tratamento de doenças miocárdicas acompanhadas de hipertrofia, e novas combinações de drogas

Country Status (33)

Country Link
US (2) US7208508B2 (https=)
EP (2) EP1666042A3 (https=)
JP (1) JP3905386B2 (https=)
KR (1) KR20020089453A (https=)
CN (1) CN1245963C (https=)
AT (1) ATE330588T1 (https=)
AU (2) AU7048401A (https=)
BG (1) BG65816B1 (https=)
BR (1) BR0109996A (https=)
CA (2) CA2404120C (https=)
CY (1) CY1105081T1 (https=)
CZ (1) CZ300549B6 (https=)
DE (2) DE10018401A1 (https=)
DK (1) DK1276476T3 (https=)
EA (1) EA006977B1 (https=)
EE (1) EE05099B1 (https=)
ES (1) ES2266216T3 (https=)
HR (1) HRP20020815A2 (https=)
HU (1) HU228387B1 (https=)
IL (2) IL152103A0 (https=)
ME (1) MEP45908A (https=)
MX (1) MXPA02009935A (https=)
NO (1) NO330311B1 (https=)
NZ (1) NZ521934A (https=)
PL (1) PL215235B1 (https=)
PT (1) PT1276476E (https=)
RS (1) RS51478B (https=)
SI (1) SI1276476T1 (https=)
SK (1) SK286075B6 (https=)
TR (1) TR200202326T2 (https=)
UA (1) UA78679C2 (https=)
WO (1) WO2001078699A2 (https=)
ZA (1) ZA200208162B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1362590B1 (en) * 2002-07-25 2004-01-07 Boehringer Ingelheim Pharma GmbH & Co.KG Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
KR20120058618A (ko) * 2003-01-31 2012-06-07 다이이찌 산쿄 가부시키가이샤 동맥 경화 및 고혈압증의 예방 및 치료를 위한 의약
CA2613417C (en) * 2005-06-27 2011-11-29 Daiichi Sankyo Company, Limited Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
JPWO2007023775A1 (ja) * 2005-08-23 2009-02-26 アステラス製薬株式会社 心房細動治療剤
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
EP1908469A1 (en) * 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
EP2432452B1 (de) 2009-05-20 2016-07-27 Boehringer Ingelheim Vetmedica GmbH Pharmazeutische telmisartan-trinklösung
FR2961105B1 (fr) 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
KR101296743B1 (ko) * 2011-02-17 2013-08-20 한국과학기술연구원 심근 비대증 진단용 바이오마커 및 이를 이용한 심근 비대증 진단 방법
WO2013024036A1 (en) 2011-08-12 2013-02-21 Boehringer Ingelheim Vetmedica Gmbh Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline
WO2014122248A1 (en) 2013-02-11 2014-08-14 Boehringer Ingelheim Vetmedica Gmbh Kit-of-parts
PT3648761T (pt) 2017-07-07 2024-06-05 Boehringer Ingelheim Vetmedica Gmbh Telmisartan para a profilaxia ou tratamento de hipertensão em gatos
KR20220054292A (ko) 2019-07-09 2022-05-02 베링거잉겔하임베트메디카게엠베하 개의 고혈압 치료를 위한 텔미사르탄
KR102398532B1 (ko) 2020-07-20 2022-05-13 한림대학교 산학협력단 중증 지주막하출혈 진단용 조성물
KR102331806B1 (ko) 2020-07-20 2021-12-01 한림대학교 산학협력단 중증 지주막하출혈 진단용 바이오 마커

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759125A (fr) 1969-11-19 1971-05-18 Boehringer Sohn Ingelheim Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3541811A1 (de) 1985-11-27 1987-06-04 Thomae Gmbh Dr K Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5175157A (en) 1985-11-27 1992-12-29 Boehringer Ingelheim Gmbh Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3736866A1 (de) 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5308853A (en) * 1991-12-20 1994-05-03 Warner-Lambert Company Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
RU2078536C1 (ru) * 1993-09-02 1997-05-10 Украинский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско Способ определения клинической эффективности применения верапамила и дилтиазема у больных гипертрофической кардиомиопатией
CZ86796A3 (en) 1993-09-24 1996-10-16 Procter & Gamble Novel deoxy and on oxygen substituted sugar derivatives of aminosteroidal compounds
US5595987A (en) * 1994-07-22 1997-01-21 The Trustees Of Columbia University In The City Of New York Method of slowing ventricular arrhythmias using zatebradine
US6083991A (en) * 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
DE19741635A1 (de) 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
TR200100062T2 (tr) 1998-07-10 2001-06-21 Novartis Ag Valsartan ve kalsiyum kanalı bloklayıcısının anti-hipertensif kombinasyonu
DE10018401A1 (de) 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
CA2435526A1 (en) 2002-07-25 2004-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
US20040138306A1 (en) 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography

Also Published As

Publication number Publication date
PL215235B1 (pl) 2013-11-29
AU7048401A (en) 2001-10-30
CA2404120A1 (en) 2001-10-25
CA2575059A1 (en) 2001-10-25
PL357827A1 (en) 2004-07-26
WO2001078699A3 (de) 2002-06-20
NO20024924L (no) 2002-10-11
RS51478B (sr) 2011-04-30
EE05099B1 (et) 2008-12-15
ES2266216T3 (es) 2007-03-01
CY1105081T1 (el) 2009-11-04
HUP0300917A2 (hu) 2003-08-28
SI1276476T1 (sl) 2006-10-31
EA200201053A1 (ru) 2003-02-27
US20040014795A1 (en) 2004-01-22
JP3905386B2 (ja) 2007-04-18
BG107103A (bg) 2003-04-30
ZA200208162B (en) 2003-10-17
IL152103A (en) 2008-07-08
AU2001270484B2 (en) 2007-01-25
CZ20023752A3 (cs) 2003-03-12
CA2404120C (en) 2008-01-22
KR20020089453A (ko) 2002-11-29
EA006977B1 (ru) 2006-06-30
US20070155679A1 (en) 2007-07-05
EP1666042A3 (de) 2006-06-21
BG65816B1 (bg) 2010-01-29
MXPA02009935A (es) 2003-02-12
EP1666042A2 (de) 2006-06-07
HUP0300917A3 (en) 2009-04-28
HU228387B1 (en) 2013-03-28
JP2003535050A (ja) 2003-11-25
DE50110262D1 (de) 2006-08-03
CN1422153A (zh) 2003-06-04
IL152103A0 (en) 2003-07-31
HRP20020815A2 (en) 2004-12-31
CZ300549B6 (cs) 2009-06-10
CN1245963C (zh) 2006-03-22
DE10018401A1 (de) 2001-10-25
EP1276476A2 (de) 2003-01-22
TR200202326T2 (tr) 2003-03-21
SK286075B6 (sk) 2008-03-05
ATE330588T1 (de) 2006-07-15
NZ521934A (en) 2007-05-31
YU76902A (sh) 2006-05-25
US7208508B2 (en) 2007-04-24
MEP45908A (en) 2011-02-10
NO330311B1 (no) 2011-03-28
DK1276476T3 (da) 2006-08-14
NO20024924D0 (no) 2002-10-11
WO2001078699A2 (de) 2001-10-25
PT1276476E (pt) 2006-09-29
SK14582002A3 (sk) 2003-03-04
UA78679C2 (en) 2007-04-25
EE200200590A (et) 2004-04-15
EP1276476B1 (de) 2006-06-21

Similar Documents

Publication Publication Date Title
BR0109996A (pt) Uso de agentes bradicardìacos no tratamento de doenças miocárdicas acompanhadas de hipertrofia, e novas combinações de drogas
BR0009320A (pt) Dibenzopiranos como antagonistas do receptor glicocorticóide para o tratamento da diabete
BRPI0413563A (pt) compostos e composições como inibidores de atividade do receptor de quìnase de tirosina
TR200201364T2 (tr) Yeni bileşikler.
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
CO5310576A1 (es) Compuestos heterocilcicos como ligandos de los receptores gabaa
CY1105060T1 (el) Νεες σουλφαμιδες και η χρηση τους σαν ανταγωνιστικων ληπτων ενδοθηλινης
TR200301841T4 (tr) Osteoporoz tedavisinde EP4 reseptör seçici.
BRPI0511477A (pt) compostos e composições como moduladores de ppar
BR9909626A (pt) Compostos que inibem a ligação de integrina a seus receptores
BRPI0720178B8 (pt) derivados de 2,3-di-hidroimidazo[1,2-c]quinazolina substituída úteis para tratar distúrbios e doenças hiperproliferativos associados com angiogênese, e composições farmacêuticas
BR0010651A (pt) Composto, uso de um composto, composição farmacêutica, e, método para o tratamento e/ou prevenção de distúrbios ou de doenças mediadas por uma ação antagonìstica de glucagon
UA83311C2 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
PE20071137A1 (es) Derivados de 8-piracin-s-espiropirimidintriona oxaquinolina como agentes antibacterianos
BR0200626A (pt) Agonistas beta3 e seus usos
UA83917C2 (en) 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
ATE289293T1 (de) Substituierte aminoalkylamid-derivate als antagonisten des follikel-stimulierenden hormons
CY1106863T1 (el) Βιολογικως δραστικες 4h-βενζο[1,4]οξαζιν-3-ονες
BR0108866A (pt) Antagonistas de receptor de il-8
MXPA04005079A (es) Variantes del dominio c2 del factor viii.
PL1522312T3 (pl) Biologicznie stabilna ciekła kompozycja FVIII lub vWF, lub kompleksu FVIII/vWF pochodzenia ludzkiego
PE20050254A1 (es) N-[3-(3-SUSTITUIDAS-PIRAZOLO [1,5-a]PIRIMIDIN-7-IL) FENIL]-SULFONAMIDAS Y COMPOSICIONES RELACIONADAS
BR0110450A (pt) Uso de agonistas receptores d4 de dopamina seletivo para tratamento de disfunção sexual
NO20072720L (no) Farmasoytiske sammensetninger basert pa NK2-antagonister for pediatrisk bruk

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]